The emerging approach of the medication represents a major development in the management of type 2 diabetes. Unlike existing medications, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide734103.alltdesign.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-60749716